Pharming Group reports preliminary 2025 revenues and announces Investor Day
(Euronext Amsterdam:PHARM),(NasdaqGM:PHARM),(Euronext Amsterdam:PHARM), Leiden, The Netherlands, January 8, 2026: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) today announced its preliminary, unaudited revenues for the full year 2025 and plans to host a virtual Investor Day on February 3, 2026, at 10:00 am EST (16:00 CET). Total 2025 revenues are estimated to […]